Subscriber Content Preview | Request a free trialSearch  
  Go

Healthcare

Actavis eyes more acquisitions

Executives say the $8.5 billion purchase of Warner Chilcott will serve as a platform for further growth. Continue reading

Actavis acquires Warner Chilcott for $8.5B

Deal represents a 34% premium to Dublin target's share price prior to May 9 disclosure of merger discussions. Continue reading

Small companies squeezed in IPO surge

The recent market uptick has benefited REITs, but growth-industry enterprises are being left behind. Continue reading

Quintiles comes out strong in market debut

The healthcare company raises nearly $950 million, while its PE owners raise almost $270 million. Continue reading

Bayer to buy Conceptus for $1.1B

The transaction is a rare piece of M&A for the German pharmaceutical company, which lost out in the bidding for Schiff Nutrition last year. Continue reading

UPS acquires Cemelog

Purchase of Hungarian pharmaceutical logistics company adds market share in Europe following Atlanta buyer's failed TNT Express bid. Continue reading

GSK shops Lucozade, Ribena brands

British biotech's noncore assets could fetch more than $1.5 billion, analysts say. Continue reading

Stage set for showdown over Elan

Eyes are on Royal Pharma as it weighs its best and final offer. Continue reading

Thermo Fisher pays richly in latest deal

The $13.6 billion transaction could be helpful for expansion, but possibly at too rich a price. Continue reading

Thermo Fisher acquires Life Technologies

Medical device maker outbids private equity firms to bolster its portfolio of testing equipment used in DNA analysis. Continue reading

Life Technologies bid valued at $11B

While the private equity consortium made up of Blackstone, KKR and Carlyle has submitted an offer, Thermo Fisher may still make a cash-heavy proposal. Continue reading

Unigene gets financing ahead of auction

The troubled maker of peptide-based drugs raises $750,000 to help it get operating and will hold an auction on April 15 of some of its assets, including a drug delivery platform. Continue reading

Meet the journalists

Andrew Bulkeley

More Healthcare journalists: Michael D. Brown , Patrick Holohan

Jim Cramer's 2013 M&A predictions

The Founder of TheStreet.com and host of Mad Money makes his predictio ... Video

More Healthcare video

The Deal on Twitter

Follow @TheDealNewsroom for the latest news across mergers and acquisitions, auctions, financings, restructurings and more!

The Deal e-newsletter

The Deal e-newsletter provides sophisticated insight and analysis on M&A, auctions, private equity, bankruptcies, debt financing and regulation, as well as the latest updates on The Deal's webcasts and events. Just click above image and select "The Deal e-newsletter (delivers on Mondays)" under the question #2.

The Deal's Webcast Series

If you have not had the chance to enjoy our Webcast Series, now is the time. Join these free 60-minute discussions and get a handle on the latest strategies and tactics in private equity, cross-border and middle market dealmaking and more.

The Deal Economy 2013

How will the new political realities in the U.S. and the shifting pressure points elsewhere shape business, finance and dealmaking in the year to come? Learn how your corporation and senior executives can help shape the discussion.